Literature DB >> 23224693

Interdisziplinärer Arbeitskreis Bewegungsstörungen (IAB): an interdisciplinary working group for promoting multimodal therapy of movement disorders.

Fereshte Adib Saberi1, Dirk Dressler.   

Abstract

Increasing complexity of therapeutic strategies for movement disorders (MD) requires multimodal therapies involving various health care professionals and physicians. Coordinating all professions involved is difficult. An interdisciplinary working group (Interdisziplinärer Arbeitskreis Bewegungsstörungen, IAB) serves to promote and improve multimodal therapies of MD. IAB was started 6 years ago in Hamburg, Germany as an interdisciplinary special interest group with about 25 physiotherapists, occupational therapists, speech therapists, nurse specialists, physicians and invited guests regularly meeting each quarter. IAB expanded and now also includes a webpage with data bases, a special interest group for Parkinson assistants, a meeting arm for organising meetings accredited by continuous medical education authorities and a publication arm for production of educational materials including a communication form and a communication calendar developed by IAB. Recently, IAB acquired a video production enterprise producing educational MD videos. In the meantime, two more IAB groups were founded in other regions of Germany. IAB's stability over more than 6 years and its expansion into more regions and other tasks documents the demand for promotion of multimodal therapies for MD.

Entities:  

Mesh:

Year:  2012        PMID: 23224693     DOI: 10.1007/s00702-012-0932-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  3 in total

1.  Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.

Authors:  D Dressler; S Berweck; A Chatzikalfas; M Ebke; B Frank; S Hesse; M Huber; J K Krauss; K-H Mücke; A Nolte; H-D Oelmann; P W Schönle; M Schmutzler; H Pickenbrock; C Van der Ven; N Veelken; M Vogel; T Vogt; F Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2015-07-16       Impact factor: 3.575

Review 2.  Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.

Authors:  Dirk Dressler; Roongroj Bhidayasiri; Saeed Bohlega; Abderrahmane Chahidi; Tae Mo Chung; Markus Ebke; L Jorge Jacinto; Ryuji Kaji; Serdar Koçer; Petr Kanovsky; Federico Micheli; Olga Orlova; Sebastian Paus; Zvezdan Pirtosek; Maja Relja; Raymond L Rosales; José Alberto Sagástegui-Rodríguez; Paul W Schoenle; Gholam Ali Shahidi; Sofia Timerbaeva; Uwe Walter; Fereshte Adib Saberi
Journal:  J Neurol       Date:  2016-10-27       Impact factor: 4.849

Review 3.  Botulinum toxin therapy of dystonia.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Raymond L Rosales
Journal:  J Neural Transm (Vienna)       Date:  2020-10-30       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.